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Chronic Kidney Disease (CKD) is considered a silent epidemic with a continuously growing 
prevalence around the world. Due to uremia many functional and morphological 
abnormalities occur in almost all systems. Mostly affected, the cardiovascular system, leads to 
diminished cardiac function that affects patients’ functional capacity and physical activity 
levels, reducing survival and increasing all-cause mortality. Systematic exercise training 
ameliorates uremia induced body deficits and significantly improves the survival of CKD 
patients. Intradialytic exercise training has been recommended as a complementary 
therapeutic modality equally important to hemodialysis. Thus the aim of this systematic 
review is to provide an update on recent advances in our understanding of how exercise 
training improves functionality of the cardiovascular system through the hemodynamic 
changes induced by habitual or intradialytic and/or home-based exercise training programs. 
Systematic exercise training induces beneficial adaptive responses and influences many 
sensitive physiological biomarkers, such as oxidative stress biomarkers that are implicated in 
the development of atherosclerosis. Additionally, exercise training decreases the 
cardiovascular risk by improving the autonomic nervous system activity and the left 
ventricular function and by reducing nontraditional risk factors such as epicardial adipose 
tissue. It seems that all these central and peripheral adaptations to exercise training 
significantly contribute to improvements in functional capacity and exercise tolerance among 
CKD patients and result in the risk reduction of CKD-associated disorders. In conclusion, 
exercise training could serve as a complimentary therapeutic strategy in CKD patients while 
health care providers should motivate patients to engage in any type of exercise training 
programs. 
Keywords: chronic kidney disease, exercise training, uremia, habitual physical activity, 
intradialytic training, home-based exercise 
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INTRODUCTION 
Chronic Kidney Disease (CKD) is characterized as a silent epidemic due to the 
continuously growing prevalence around the world and with a prevalence of 7.2% in patients 
aged >30 years old and ranging from 23.4% to 35.8% in patients aged >64 years, CKD is a 
major health problem [1]. In addition, it has been estimated that the percentage of people aged 
>60 years will increase from 11% to 22% in 2050, thus the prevalence of CKD will be 
increased [2] and this condition will have an enormous socio-economic impact. Thus, new 
strategies for CKD prevention and new complimentary treatments, which could ameliorate all 
the CKD consequences, should be found. 
Aging, hypertension, diabetes, glomerulonephritis, cystic kidney disease and other 
diseases are responsible for the irreversible deterioration of kidneys structure and function. 
Unfortunately, the asymptomatic nature of CKD especially in the early stages does not allow 
the early diagnosis and many opportunities for prevention and treatments could be lost. 
Consequently, a significant loss of kidney function occurs which is accompanied from toxins 
accumulation in the plasma and progressively the clinical syndrome of uremia appears with 
numerous consequences. When the loss of kidneys function is significant to a level that less 
than 10% of kidneys function remains, this condition is characterized as end-stage renal 
disease (ESRD) and the renal replacement therapy of hemodialysis is necessary. Although the 
technology of hemodialysis therapy has improved all these years, it still induces numerous 
complications which are responsible for the significant clinical problems appeared in CKD 
patients and for the low levels of quality of life that are characterized them. 
CKD patients and especially ESRD experienced several functional limitations such as 
fatigue, muscular weakness, low cardiorespiratory fitness, exercise intolerance, which induce 
disability and morbidity and contribute to the poor survival prognosis that these patients 
presents [3]. Moreover central and peripheral factors met in CKD patients are responsible for 
the exercise intolerance and especially cardiac dysfunction, metabolic abnormalities, impaired 
Autonomic Nervous System (ANS) activity, muscle wasting and muscular weakness are 
components of uremic myopathy and cardiomyopathy [4]. All these consequences lead CKD 
patients to inactivity and hypokinesis and accordingly increase the risk for cardiovascular 
mortality. 
Cardiovascular disease (CVD) is remaining the most common cause of death in CKD 
patients [5]. As the kidneys function falls the cardiovascular risk increases [6], especially 
ESRD patients are in 40-50 times higher risk than the general population to die from 
cardiovascular events [7]. It has been found that 40% of the patients that have started 
hemodialysis therapy presents coronary artery disease, while the 85% of these patients 
manifested disturbances in left ventricular structure and function [8]. Several mechanisms 
have been proposed in the pathogenesis of CVD in CKD patients such as hypertension, 
dyslipidemia, activation of the renin-angiotensin system, endothelial dysfunction, oxidative 
stress and inflammation. Exercise training has proved to be an effective intervention, which 
have beneficial impact on cardiovascular and musculoskeletal system health. Moreover, 
exercise training has been recommended as a complementary therapeutic modality in the 
CVD prevention [9, 10]. 
Specifically, it has been found that systematic exercise training induces 
cardioprotective mechanisms by reducing traditional risk factors and can improve the low 
levels of cardiorespiratory fitness, which presents CKD patients and are irreversible 
connected with mortality. In order to increase the positive health effects of exercise and 
participant’s compliance with the training programs different modalities of exercise training 
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programs have been applied to CKD patients such as intradialytic, home-based or habitual 
exercise training programs. 
Thus the aim of this systematic review is to provide an update on recent advances in 
our understanding of how exercise training improves functionality of the cardiovascular 
system through the hemodynamic changes induced by habitual or intradialytic and/or home-
based exercise training programs. 
METHODS 
A systematic review was conducted searching Pubmed and Scopus by using the 
Cochrane and PRISMA guidelines. A comprehensive literature search was conducted from 
June 2015 through October 2015. We used PubMed, Science Direct and Scopus or Google 
Scholar to search for studies that investigated the intra-renal hemodynamic changes induced 
by habitual or intradialytic and/or home-based exercise training programs on cardiovascular 
system in CKD patients. Eligibility of the studies based on titles, abstracts and full-text 
articles was determined by two reviewers. Studies were selected using inclusion and 
exclusion criteria. Figure 1 shows the progress of the literature screening. In the current 
review only studies that met the following criteria were included: studied CKD patients and 
patients on hemodialysis treatment, assessed cardiovascular system function in CKD patients; 
addressed randomized control trials or controlled trials or clinical trials or pilot studies 
designed to evaluate the intra-renal hemodynamic changes; lack of a drug or diet 
interventions on the cardiovascular system or lack of uremic animals’ models, and full text 
articles written in English. Studies were excluded when they referred to patients on peritoneal 
dialysis and concerned low quality studies, namely studies with methodological flaws or lack 
of reporting. 
RESULTS & DISCUSSION 
Cardiovascular abnormalities in CKD patients 
CKD is associated with increased risk for cardiovascular events and mortality. 
Especially ESRD who receive hemodialysis therapy experienced several cardiovascular 
complications such as coronary artery disease, congestive heart failure, arrhythmias and 
hypertension. High blood pressure, insulin resistance, dyslipidemia, vascular calcification, 
chronic inflammation, oxidative stress, endothelial dysfunction and other metabolic 
disturbances contribute to structural and functional changes in myocardium and accordingly 
lead to cardiac dysfunction and to increase cardiovascular events in patients with CKD. 
Left ventricular hypertrophy (LVH), dilatation, systolic and diastolic dysfunction are 
components of the condition who is used to describe the effects of CKD on myocardium, 
termed as uremic cardiomyopathy leading to changes in the systemic hemodynamics affecting 
the structural and functional characteristics of the in myocardium. The main result of uremic 
cardiomyopathy is LVH which is manifested in the 26% of patients in stage 3 of CKD and in 
the 75% of patients on hemodialysis therapy [8] and is considered as an independent predictor 
of survival in CKD patients [11]. LVH is the result of hypertension and arteriosclerosis which 
occur due to pressure and/or volume overload that induced from anemia, arteriovenous fistula 
and hypervolemia in CKD patients [12] and it could be characterized as an adaptive response 
to these complications. Hypertension and increased volume overload, probably induce 
cardiomyocyte hypertrophy and vascular remodeling [13]. Additionally, an excessive 
activation of the renin-angiotensin-aldosterone system [14] as well as the phosphoinositide-3 
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kinase (PI3K)-Akt pathway contributes further to the development of LVH in these patients’ 
population [15]. LVH also is responsible for the left ventricular dilatation and dysfunction 
and for the decreased left ventricular ejection fraction. 
In addition other factors influence the development of cardiac diseases in CKD 
patients such as increased levels of homocysteine [16], hyperparathyroidism, 
hypoalbuminaemia, oxidative stress and inflammation. Anemia and impairment mineral 
metabolism, stimulate hyperphosphatemia and elevated parathyroid hormones levels leading 
to vascular calcification by altering the phenotype of vascular smooth muscle cells [14]. 
Hypovitaminosis D, which is a common disturbance of CKD patients, contributes to 
myocardial hypertrophy and it has been associated with cardiovascular mortality and sudden 
cardiac death [17]. A possible explanation is the multifactorial role of vitamin D on heart 
remodeling such as cardiac cell contraction, proliferation, hypertrophy, differentiation as well 
as protein and collagen expression [14]. 
Functional capacity limitations in CKD patients 
CKD patients are characterized by very low levels of functional capacity which is 
responsible for the exercise intolerance and early fatigue that these patients experienced. 
Consequently, due to the reduced levels of aerobic capacity ESRD have to deal with many 
difficulties in performing the everyday living activities. Several factors are responsible for the 
low functional ability found in CKD patients. For example, VO2peak in ESRD patients is 
decreased by ≈50% compared to healthy age-matched values and therefore the activities of 
these patients are limited to those intensities require low level of aerobic capacity [18]. 
Limitations in oxygen delivery during exercise training due to cardiac dysfunction and 
complications in blood circulation are considered as the major causes for the reduced 
VO2peak that CKD patients present. 
Painter [19], suggested that many factors interact and are responsible for the low 
levels of aerobic capacity seen in CKD patients, such as decreased cardiac output which is 
attributed to the low heart rate, low arterial oxygen content induced from anemia and 
abnormal muscle function which is attributed to uremic myopathy and neuropathy. 
Additionally, malnutrition, impaired energy metabolism, secondary hyperathyreoidism and 
inactivity enhance the symptoms of uremic myopathy. 
Changes induced by uremic myopathy in skeletal muscles are responsible for the 
muscle wasting and the preliminary fatigue in CKD patients. According to studies decreased 
fiber size, especially atrophy and loss of IIα and IIx fibers, reduced capillary density and 
peripheral activation [20] and a significant reduction in the mean diameter of both fiber types 
have been found in CKD patients [21]. Moreover, disturbances in mitochondrial morphology 
found in CKD patients possibly explain the increased fatigability [22]. 
Central or peripheral uremic neuropathy resulted in cardiac autonomic nervous 
system (ANS) dysfunction, which is a common feature in patients receiving hemodialysis 
therapy. A reduction in both sympathetic (SNS) and parasympathetic nervous system (PNS) 
occurs in uremic dysautonomia and especially parasympathetic failure during hemodialysis is 
a common complication in uremic patients [23]. Spectral analysis of heart rate variability 
(HRV) is the most commonly noninvasive method used for the assessment of ANS activity 
and autonomic dysfunction and is usually expressed with depressed HRV in CKD patients. In 
addition, HRV is considered to be an independent predictor of mortality in hemodialysis 
patients [24]. Decreased HRV due to dysfunction of the cardiac ANS is a known complication 
of hemodialysis patients and is associated with an increased risk of ventricular arrhythmias 
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and sudden death. Furthermore, it has been reported that a sympatho-vagal imbalance in the 
cardiovascular system which is expressed with reduction in the indices of SDNN, LF and 
LF/HF ratio is related with sudden cardiac death [25]. Many studies have supported the notion 
that hemodialysis therapy itself induces changes in HRV of uremic patients [23, 26-29]. 
Specifically, it has been observed decreased sympathetic activity during hemodialysis [26] in 
contradiction to the results of some other authors demonstrating a shift in sympathovagal 
balance towards sympathetic activation during the hemodialysis process [27, 28]. 
Exercise training can ameliorate or delay the progress of all these consequences of 
CKD. Since the early ’80 many different modalities of exercise training programs have been 
applied in CKD patients such as home-based, habitual, center-based and intradialytic. All 
these studies have documented that exercise training is possible in CKD patients, due to the 
hemodynamic changes inducing beneficial responses by improving functional capacity and 
overall health related quality of life. 
Hemodynamics changes during exercise training 
During exercise in healthy subjects, the induced hemodynamic changes activate many 
beneficial mechanisms, which in turn cause beneficial adaptations with renoprotective and 
cardio-protective effects. Furthermore, in healthy subjects during exercise and especially 
during the first minutes, a rapid increase in heart rate, blood pressure and stroke volume take 
place. Accordingly an elevation n cardiac output occurs as an adaptive response to the 
increased muscle metabolic demands for oxygen. Additionally, it has been observed that in 
response to exercise, hematocrit and blood viscosity are increased, which in turn induce 
beneficial cardio-protective effects by promoting the nitric oxide (NO) production [30]. 
Moreover, the increase in blood viscosity during exercise seems to contribute to the 
circulatory resistance reduction [30]. Also, during exercise training, the sympathetic nervous 
system activity is crucial for the blood flow and the blood pressure regulation [31]. Animal 
studies [32, 33] have revealed that exercise has beneficial effects on coronary 
microcirculation because during submaximal exercise training a slightly or a continued 
increase of α-adrenergic and β-adrenergic tone occurs and accordingly an increased receptor 
responsiveness to adrenergic stimulation is adopted. Consequently, a reduction in the 
circulating catecholamine levels is observed due to increased adrenergic sensitivity to 
stimulation. Both coronary and peripheral resistance vessels benefit as their constriction is 
greater and probably the myocardial oxygen extraction could be enhanced even after exercise 
[34]. 
Patients with CKD are characterized by a decreased cardiac response during exercise 
due to cardiac and other abnormalities such as anemia, arteriovenous fistoula, hypertension, 
etc., which affect cardiac pre-load and after-load (figure 2). Blomqvist [35], who described 
the cardiovascular adaptations to physical exercise proposed that stroke volume could be 
elevated during exercise by increasing the cardiac dimensions or by enhancing the 
performance characteristics of the heart. Cardiac functional and structural abnormalities met 
in CKD patients, due to uremic cardiomyopathy, probably are responsible for the decreased 
cardiac response during exercise, observed in these patients. Moreover, increased levels of 
endothelin 1, which is a vasoconstriction protein, have been observed in CKD patients [36] 
and likely increase the peripheral resistance in these patients. 
Also, impaired cardiac autonomic control is reflected in the increased levels of resting 
heart rate in CKD patients. However, during exercise heart rate response is decreased and 
only a small amount of CKD patients can reach the predicted heart rate [37]. The decreased 
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heart rate response during exercise is attributed to impaired cardiac autonomic nervous 
system and myocyte dysfunction, which characterize CKD patients [38]. Moreover, anemic 
dialyzed patients present higher cardiac output and stroke volume and as a consequence an 
increased prevalence of left ventricular hypertrophy and left ventricular dilatation are 
observed [39]. Treatment of anemia with erythropoietin in CKD patients seems to have a 
beneficial impact on hemodynamics as it has been found that patients after treatment 
presented a tendency to decrease cardiac output and left ventricular mass and as a result 
exercise tolerance improved [39]. 
However, varied cardiac adaptations occur during exercise training in different 
positions. For example a study by Poliner et al [40] who examined the cardiac responses to 
exercise in upright and supine positions supported that during supine position the Frank-
Starling mechanism is activated due to increased left ventricular end-diastolic volume 
compared with upright or sitting position. Specifically, the increase in left ventricular end-
diastolic volume during low-level upright exercise training was doubled compared to exercise 
training in supine position [40]. Thus, exercise training during hemodialysis therapy where 
the feet are elevated and fixed on the cycle ergometer probably induce even more beneficial 
cardiac effects compared to non-dialysis exercise training.  
Especially when exercise training is during hemodialysis therapy, the large fluid 
volume induces changes in cardiovascular response to exercise. Moore et al [41], who 
described the cardiovascular changes during intradialytic submaximal stationery cycling, 
found that during the first two hours hemodialysis therapy does not affect the cardiovascular 
response to exercise. In contrast, in the same study the authors revealed that after 3 hours of 
hemodialysis therapy hemodynamic changes, which contributed to cardiovascular 
decompensation, occurred. These findings suggested that after the second hour of 
hemodialysis therapy exercise training should be precluded [41]. The hemodynamic 
instability after the third hour of hemodialysis is attributed to the fact that a sympathetic 
nervous system withdrawal occurs and is responsible for the inappropriate decrease in heart 
rate and blood pressure presented in hemodialysis patients. 
There is limited evidence regarding the beneficial effects of exercise training in 
kidney function. An animal study by Ito et al [42], who examined the chronic effects of 
running in Zucker diabetic fatty rats showed that at early stages of diabetic nephropathy, 
running beneficially induce alterations in kidney oxidative stress status. More precisely, the 8 
weeks running on a treadmill increased NOS activity and protein expression of eNOS and 
nNOS proteins in the renal cortex of the diabetic rats, suggesting that exercise training may 
provide renoprotective effects and delay the progression of renal failure at the early stages of 
diabetic nephropathy [42]. In addition, the renoprotective effects of exercise training have 
been proved in a study by Tucker et al [43], where the authors compare the effects of high 
intensity interval training with light intensity exercise training or with a sedentary group of 
rats. The exercise program of running on a treadmill lasted 8 weeks. After completing the 
training period, the authors found that the group who followed the interval training had 
elevated mRNA expression of superoxide dismutase (Sod) 1 and catalase (Cat) in the renal 
tissue [43]. Moreover, the results of the same study revealed that interval exercise training 
had beneficial effect on inflammation, which was expressed by an up-regulation to Tnfrsf1b 
mRNA expression in kidney tissue [43].  
The results of these histopathological studies demonstrated that exercise training 
through an up-regulation in oxidant and antioxidant status is possible to influence kidney 
function beneficially. Therefore, the renoprotective effects of exercise training can ameliorate 
the renal failure progression by reducing oxidative stress and inflammation. However, these 
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studies have been applied in animal and specifically in animal models of rat and we can only 
hypothesize that this renoprotective effects could be activated in humans. 
On the other hand, the fact that systematic exercise training provides cardio-
protection properties against cardiovascular diseases, through adaptations and mechanisms 
that are activated by the hemodynamic changes during exercise, is well established. This 
protection could be acute or chronic for example acute protection could be induced 
immediately after an acute bout of exercise training. Unfortunately this protection lasts only 3 
hours while chronic is initiated 24 hours after exercise training and could persist 9 days after 
completing 5 day exercise training routine [44]. It has been suggested that acute protection 
occurs by the activation of the antioxidant mechanisms and especially by the enzyme 
superoxide dismutase, which is found in the mitochondria of the ventricular myocytes [45]. 
Meanwhile, in chronic protection many beneficial mechanisms have been described that are 
contributing to cardio-protection [46], such as alterations in oxidant and antioxidant status, in 
mitochondrial protein expression etc. 
In left ventricular dysfunction, which is the most common cardiac abnormality that 
CKD patients present, cardiac output does not increase in response to exercise. As a 
consequence an elevation in systemic vascular resistance occurs. In a study by Sowton and 
Burkart [47], where they estimated the hemodynamic changes during continuous exercise on 
a bicycle ergometer in cardiac patients, changes were found in: heart rate, blood pressure, 
cardiac output, stroke volume, arteriovenous oxygen difference, oxygen uptake, total 
peripheral and pulmonary resistance and in left ventricular work. More precisely, during 
continuous steady exercise, patients were examined for hemodynamic response at least 30 
minutes while no drugs were allowed to be given [47]. 
Effects of home-based exercise training programs 
Home-based exercise training programs have shown to improve functional ability in 
the CKD patients [48] (table 1) and these results are more profound when home-based 
exercise training is combined with center-based or intradialytic exercise programs. However, 
in home-based exercise programs the participation was lower compared the other forms of 
exercise training programs due to the lack of motivation. Specifically, Nomoyama et al [49] 
applied for 12 weeks an exercise program, which compared home-based and intradialytic 
exercise training. The results showed that the participation in the intradialytic exercise 
program was higher (89%) compared to home-based program (56%) while the differences 
were attributed to the fact that in intradialytic exercise training program, the patients were 
more aware of the benefits of exercise because the exercise was taking place during their 
usual therapy [49]. In order to maximize results in functional capacity, it is suggested that a 
combination of a home-based exercise program with other types of training is implemented.  
Effects of habitual exercise training 
Generally, hemodialysis patients are characterized by low physical activity levels and 
even habitual exercise training programs might improve the functional ability of these 
patients (table 2). Cupisti et al [50], who evaluated the habitual physical activity levels during 
a mid-week interdialytic period of 48 hours in 50 ESRD patients, found that patients revealed 
reduced daily METs value by 14% compared to normal subjects and decreased number of 
steps/day by 52.4%. In addition these results were correlated with patients’ dietary nutrient 
intake and body composition [50]. These results confirmed that malnutrition and muscle 
atrophy are important factors which leads to inactivity in CKD patients. However, in another 
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study by Kosmadakis et al [51], increased exercise tolerance measured with Borg Rating of 
Perceived Exertion (RPE) after 1 month and 6 months exercise training was found and these 
beneficial effects did not get lost after 6 months of no training. In the same study [51] 6 
months of habitual exercise training weren’t enough to induce changes in arterial stiffness 
biomarkers and baroreflex (BRS) sensitivity. The results of this study [51] indicate that 
habitual physical activity is not enough to induce beneficial results in the CKD patient’s 
cardiovascular system and systematic exercise training is needed.  
In another study by Matsuzawa et al [52] habitual exercise training found to be 
related with high density lipoprotein cholesterol (HDL-C) levels, which are related with 
cardiovascular mortality. The authors after examining habitual physical activity levels using 
accelerometers in 116 CKD patients on hemodialysis, demonstrated that increased physical 
activity levels were correlated with improved prognosis. Indeed, in 1980 a study by Keys [53] 
found that in men, low levels of HDL-C were related to coronary artery disease mortality 
while high levels of HDL-C to other causes of mortality. In a review by Besler et al [54], the 
authors described the mechanisms of how high HDL-C levels induce cardioprotective effects 
in the vasculature and indisputably the fact that HDL-C accelerates nitric oxide (NO) 
synthesis is proved to be a crucial mechanisms, which enhances the atheroprotective effects.  
Moreover, a study of Hamasaki et al [55] in heart failure patients found that a 
correlation existed between physical activity levels and plasma BNP levels, even after an 
adjustment with age and BMI. B-type natriuretic peptide (BNP) is widely used as a 
cardiovascular risk biomarker and an increase in serum levels has been related with the 
degree of left ventricular dysfunction, severity of congestive heart failure symptoms and 
ultimately poor prognosis [56]. 
 
Effects of exercise training on non-dialysis day 
Numerous studies in the literature have examined the effects of different modalities 
of intradialytic exercise training programs in ESRD patients (table 3). Both aerobic and 
resistance exercise training programs induce favorable effects in aerobic capacity, in muscle 
strength, and in cardiac function of ESRD patients. Improvements in VO2peak of between 8% 
and 48% have been reported in most studies after applying aerobic or combined, (aerobic and 
resistance) exercise training programs lasting between 3 to 12 months [22, 36, 37, 57-60]. 
However, in a study by Pechter et al [61] an improvement of 2% in VO2peak was observed 
after participants underwent a water-based exercise training program. Even though the 
intensity of the exercise training program was low in this study leading to low increase in 
patients’ aerobic capacity , the authors claimed that the water-based exercise is superior to 
land-based exercise due to fact that buoyancy give an advantage to patients to exercise harder 
[61]. Moreover, in this study in the exercised group a significant reduction in proteinuria was 
observed and this finding has an important clinical impact because proteinuria has been 
associated with the rate of renal failure and this reduction might limited the renal decline [62]. 
Exercise training was usually prescribed for 2-3 times/week, with duration ranging 
from 30-50 min per session. In most studies the authors reported that the exercise training 
programs were supervised from qualified health professionals. In none of the studies any 
serious complications resulted from the participation in the exercise training programs, were 
reported. 
Moreover, exercise training in CKD patients resulted in improvement in their 
functional capacity [59, 63-65], which means that they were capable to complete their 
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everyday living activities easier, adopt a healthier way of life and improve overall quality of 
life. Moreover, the cardiovascular benefits of both resistance and aerobic exercise training 
were reflected in improvements in lipid profile [57, 66], in echogardiography indices [37], in 
cardiac autonomic function [58], in arterial stiffness [67], in vessels diameters [68] and size 
[69] and in blood pressure [68]. The cardiovascular response to exercise training induces 
changes and accordingly increases heart rate and stroke volume but also reduces the 
peripheral vascular resistance. These hemodynamics changes induce favorable cardiovascular 
adaptations with clinical significance. It has been demonstrated that exercise training benefits 
vascular health by inducing structural modifications such as angiogenesis [70] and vascular 
remodeling [71]. 
Effects of intradialytic exercise programs 
Intradialytic exercise training with stationery bicycles is the most favorable type of 
exercise training among ESRD patients. The patients usually cycle for 10-45 min and 
progressively resistance is applied to the bicycle wheels [72-82]. Also, resistance exercises 
have been applied in intradialytic exercise training programs without serious complications 
and induced beneficial effects on patient’s muscular strength [83-90] (add Johansen KL et al, 
JASN, 2006). Usually resistance exercise training includes 1-3 sets of every exercise and 8-15 
repetitions with weights of 0.5-2.0 libres (lbs).  
The exercises sessions occurred at the hemodialysis centers during the first two hours 
of the hemodialysis treatment (table 4). According to Moore et al [41] is more safe exercise 
training programs to be applied during the first 2 hours because cardiac function is more 
stable. According to authors after 3 hours on hemodialysis cardiac output and mean arterial 
blood pressure were decreased and these changes were associated with cardiovascular 
instability [41]. Probably the main reason for this cardiovascular instability is ANS 
dysfunction seen in CKD and especially impaired baroreflex sensitivity, which characterized 
CKD patients and is associated with mortality [91].  
The findings of all studies that applied intradialytic exercise training programs 
revealed benefits in aerobic capacity and muscular strength. A study by Wilund et al [77] 
found that the thickness of the epicardial fat layer was reduced by 11% after a 4 months 
exercise training program.  This finding has an important beneficial clinical effect since 
epicardial fat is associated with increased levels of inflammation and atherosclerosis [92]. 
Although, in the same study a significant reduction in oxidative stress biomarker was found, 
no significant changes in traditional inflammation blood indices such as IL-6 and CRP was 
observed [77], probably due to the fact that cytokine levels in the blood are not related to the 
levels of cytokines in the tissue/organ [92]. Inflammation is associated with oxidative stress 
and these two mechanisms are implicated in the pathogenesis of CVD. 
Discussion-Conclusions 
All modalities of the exercise training programs induce beneficial effects in CKD 
patients (figure 3) by playing a cardioprotective role. Systematic exercise training increases 
functional ability, improves the quality of hemodialysis therapy, and improves the overall 
health related quality of life. Aerobic type of exercise training is the predominant type of 
training used in most of the published studies compare to other types of training such as 
resistance or combined. During exercise training many central and peripheral adaptations 
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occurs which in turn induce all the aforementioned beneficial effects in the cardiovascular 
system. Even a short period of exercise training per day lasting no more than 15 min is 
possible to reduce mortality in otherwise healthy individual by 14% [93] highlighting the 
important of regular physical activity in the chronic diseases patients. 
CKD and hemodialysis therapy are responsible for many complications in CKD 
patient’s cardiovascular health. One of the serious consequences of CKD in the 
cardiovascular system is impairment in the autonomic cardiovascular control, which is 
reflected in the depressed HRV. Although, hemodialysis procedure ameliorate clinical 
outcomes and survival in uremic patients, chronic exposure to hemodialysis seems to induce 
changes in HRV [94]. In addition autonomic neuropathy induce alterations in HRV and there 
is evidence that high fluid overload met in hemodialysis patients also impairs ANS activity, 
leads to hypertension and left ventricular hyperthrophy where enhances cardiac mortality 
[95]. It has been found that during the ultrafiltration procedure of the hemodialysis therapy an 
acute decrease in parasympathetic function and a relative hyperactivity of sympathetic 
nervous system takes place [96]. Moreover, it has been supported that daily hemodialysis 
induced structural effects on the heart of uremic patients which was associated with 
alterations in HRV [97]. In particular, ANS dysfunction worsens as the disease progresses 
[98, 99] and the duration of hemodialysis session increases [100] while age is an important 
player which contributes in the parasympathetic dysfunction often seen in CKD patients 
[101]. 
Moreover, impairment in the ANS function contributes to blood pressure 
dysregulation in CKD patients by reducing the baroreflex sensitivity leading to blood pressure 
instability during and after the hemodialysis session. Baroreflex sensitivity is an index of 
cardiac autonomic control and reflects the interaction between cardiac sympathetic and 
parasympathetic system [102]. Sympathetic overactivity is responsible for the depressed 
values in baroreflex sensitivity [102] which are related to arrhythmias [103] and consequently 
increase mortality in CKD patients. Exercise training has proved to benefit baroreflex 
sensitivity [51, 104], by improving endothelial function and endoneurial blood flow [105]. 
In conclusions, systematic exercise training induces a variety of hemodynamics 
changes that benefit CKD cardiovascular health. Regular exercise training induces beneficial 
adaptive responses and influences many sensitive physiological biomarkers that are 
implicated in the development of atherosclerosis. Additionally, exercise training decreases the 
cardiovascular risk by improving the autonomic nervous system activity, the left ventricular 
function and by reducing nontraditional risk factors such as the epicardial adipose tissue. It 
seems that all these central and peripheral adaptations to exercise training significantly 
contribute to improvements in functional capacity and exercise tolerance among CKD 
patients and results in the risk reduction of CKD-associated disorders and comorbidities. 
Exercise training has all the appropriate therapeutic characteristics to serve as a 
complimentary strategy in CKD patients while health care providers should motivate patients 
to engage in any type of exercise training programs. 
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Table 1. Home-based exercise training programs 
Authors Study groups Exercise intervention Results 
  Duration Type of exercise prescription  
Nonoyama 
2010 [49] 
Home-based & 
intradialytic 
exercise group  
(n= 9) 
3 months  
 Intradialytic 
 Home-based 
20-30 aerobic per session, 6 exercises 
with exercise bands and 0.5-2.0 lb free 
weights, 2- 3 times/week at home & 
intradialytic 20-30 min cycling at 2-4 
RPE, flexibility and strengthening 
exercises of upper & lower extremities 
with bands of 0.5-2 lb, 1-3 set x 15 
repetitions 
 13.3% 2MWT (m) 
16.2% TUG (s) 
10.4% KDQOP physical composite score 
6% DASI VO2peak (mi/min/kg) 
Mustata 
2011 [106] 
Exercise group 
 (n= 10) 
Control group 
(n= 10) 
12 months 
 Supervised 
 Home-based 
2 times/week aerobic training, 40-60% 
VO2peak increased by 5-10% weekly to a 
maximum of 60 min/ 
3 times/week walking started in the 2nd 
month  
15.1 % VO2peak 
78.6% Endurance time 
5.5% Augmentation index 
Baria 2014 
[107] 
Centre-based 
(n=10) 
Home-based (n=8) 
Control group  
(n= 10) 
3 months 
 Centre-based 
exercise 
 Home-based 
exercise  
30 min aerobic exercise in treadmill at 
VT, 3 times/day (every 4 weeks the 
duration increased by 10 min) 
Aerobic exercise 3 times/day 
8.6% VO2peak 
50% Sit-to-Stand 
11.7% 6-MWT 
6.7% Visceral fat 
1.3% Waist circumference 
2% Total body fat 
10.3% Mean blood pressure (mmHg) 
Takashi 
Aoike 2015 
[48] 
Home-based 
exercise group 
(n=14) 
Control group 
(n=15) 
3 months Home-based Aerobic training (walking) 30 min, 3 
times/week (every 4 weeks the duration 
increased by 10 min) 
8.3% VO2peak (ml/kg/min) 
17% VE (L/min) 
10.1% 6-MWT (m) 
21.8% 2-Min Step Test (steps) 
8.1% Sit & Reach Test (cm) 
28.8% Arm Curl Test (repetitions) 
39.5% Sit & Stand Test (repetitions) 
34% Back Scratch Test (cm) 
10.4% Time up & Go test (s) 
2MWT: 2 min walk test; TUG: Time up & go; KDQOL: Kidney Disease Quality of Life questionnaire; STS: Sit-to-Stand Test;6-MWT: 6min walk test; VT: ventilatory threshold 
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Table 2. Habitual exercise training 
Authors Study groups Exercise intervention Results 
  Duration Type of 
habitual 
physical 
activity 
Exercise 
training 
program 
 
Cupisti 2011 
[50] 
Habitual activity group 
(n= 50 HD patients) 
Control group  
(n=33 healthy subjects) 
With a wireless 
multisensory activity 
monitor physical 
activity levels were 
evaluated for a 48 hours 
period 
Walking no 13.3% Daily physical activity levels 
(METs) 
37.7% Time spent on activities (min) 
52.4% Number of steps 
 
Kosmadakis 
2012 [51] 
Exercise group  
(n=18 CKD patients  
stage 4 or 5 ) 
Control habitual physical activity 
group 
(n=14 CKD patients stage 4 or 5) 
6 months, 
5 times/week 
Every day 
living activities 
30 min 
walking at 
RPE 12-14 
Arterial stiffness 
3% Carotid-femoral (m/s) 
- Carotid-radial 
6.8% Augmentation index 
16.1% BRS (ms/mmHg) 
 
Matsuzawa 
2013 [52] 
Habitual physical activity 
evaluation (n=116) 
An accelerometer 
pedometer used to 
evaluate the habitual 
physical activities for 1 
week 
Walking-only 
1 patient 
participate in 
the activity of 
cycling or 
swimming 
no HDL-C Levels 
Hamasaki 
2015 [55] 
(n=30 pre-diabetes patients) 
(n= 30 patients with early untreated 
type II diabetes) 
A triaxial accelerometer 
used for 1 week 
Daily physical 
activity 
no Physical activity levels 
BNP 
 
HD: hemodialysized; BRS: Baroreflex sensitivity; BNP: B-type natriuretic peptide; 
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Table 3. Exercise training in non-dialysis day 
Authors Study groups Exercise intervention Outcomes 
  Duration modality prescription  
Goldberg 
1980 [57] 
 8 months Aerobic Bicycle ergometer, walking, 
jogging 40-75% VO2peak 
32.5% Exercise duration (s) 
16.6% VO2peak (ml/kg/min) 
3.7% Fasting glucose levels (mg/dl) 
30.7% Glucose disappearance rate (%/min) 
40.6% Fasting plasma insulin (μU/ml) 
27.9% Triglyceride (mg/dl) 
29.8% Very-low density  
lipoprotein triglyceride (mg/dl) 
21.8% HDL (mg/dl) 
24.1% Total cholesterol (mg/dl) 
27.7% Low-density lipoprotein cholesterol 
(mg/dl) 
Kouidi 1998 
[22] 
Exercised group 
(n=7 HD patients) 
6 months Aerobic 10 min cycle ergometry or 
treadmill, 50 min calisthenics 
& steps, swimming or ball 
games, 10 min resistances 
exercises with low-weight, 10 
min cool-down, 
 3 times/week 
28.8% Exercise time (min) 
48% VO2peak (ml/kg/min) 
 55.7% Max left leg isometric force (N) 
40.2% Max right leg isometric force (N) 
12.6 Left leg conduction velocity (m/s) 
12.2% Right leg conduction velocity (m/s)  
9% Left leg distal time (ms) 
10.8% Right leg distal time (ms) 
Deligiannis 
(a) 1999 [37] 
Exercised group   
(n=16 HD patients), 
Home-based exercised 
group  
(n=10 HD patients), 
Control group  
(n=12 HD patients) 
Group of healthy subjects 
(n=15) 
6 months  10 min cycle ergometry or 
treadmill, 50 min calisthenics 
& steps, swimming or ball 
games, 10 min resistances 
exercises with low-weight, 10 
min cool-down, 
 3 times/week 
42.7% VO2peak (ml/kg/min) 
32.5% Exercise time (min) 
32.5% METs 
40.6% VE (l/min) 
5.3% VE/VO2max 
3.6% LVIDd (mm) 
6.1% LVM (g) 
11.2% LVMI (g/m2) 
Deligiannis 
(b) 1999 [58] 
Exercised group  
(n=30 HD patients) 
Control group  
(n= 30 HD patients), 
Group C  
(n=30 nonuremic 
6 months Aerobic 10 min cycle ergometry or 
treadmill, 50 min calisthenics 
& steps, swimming or ball 
games, 10 min resistances 
exercises with low-weight, 10 
min cool-down, 
41.1% VO2peak (ml/kg/min) 
31.2% Exercise time (min) 
27.2% HRV index 
18% SDNN (s) 
5% Sum of beats  
40% HRV index<25 (no.) 
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patients)  3 times/week 
 
 
33.3% Arrhythmias-Lown class>II (no.) 
 
Pechter 2003 
[61] 
Exercise group  
(n=17 CKD patients) 
control group  
(n=9 CKD patients) 
3 months Aerobic water 
based exercise 
10 min warm-up, 10 min 
cardiovascular exercises, 10 
min cool-down,  
2 times/week 
2% Vo2peak (ml/kg/min) 
19.8% O2pulse (ml/beats/min) 
15% VE (l/min) 
34.4% LPO (ng/ml)  
15% GSH (μM) 
33.3% GSSG/GSH 
Leaf 2003 
[108] 
Exercise group  
(n=5 CKD patients) 
6 week Exercise with 
heat control& 
home-based 
exercise 
Isometric hand-grip 
contractions at 30-40% of 
MVC,  
4 times/week 
100% Left cephalic vein no tourniquet (cm2) 
100% Left cephalic vein with tourniquet (cm2) 
 
Nindl 2004 
[109] 
Exercised group  
(n=10) 
3 months Resistance 
training 
2 set of 10-15 repetitions of leg 
press, leg extension, leg curl, 
chest press, compound row, 
lateral raises, biceps curls, 
triceps extensions, abdominal, 
2 times/week 
6MWT (m) 
STS (s) 
Peak torque of the quadriceps 
16.5% Total IGF-I (ng/ml) 
18.7% Ternary IGF-I (ng/ml) 
22.9% IGF-I/IGFBP-3N(x10) ratio 
Mustata 2004 
[67] 
Exercised group  
(n=11) 
3 months Aerobic 5-10 min warm-up, 40-50 min 
conditioning exercise 
(treadmill or bicycle), 5-10 min 
cool-down, 2 times/week 
28.2% Arterial stiffness (u) 
10.9% Pulse pressure (mmHg) 
 
Kuge 2005 
[110] 
Exercised group  
(n=8 HD patients) 
Control group  
(n=7 healthy subjects) 
6 weeks Hand grip 
exercise training 
50-150 repetitive handgrip 
contractions, at 60% of 
maximum force  
4 times/week 
24.5% Maximum strength (N) 
63.1% Maximum endurance (sec) 
Clyne 2005  Exercised group 
(n=7 predialysis patients) 
Control group  
(n=5 predialysis patients) 
Exercise group  
(n=6 healthy subjects) 
3 months Resistance 
training 
20 repetitions of 60% of 1 RM,  
3 times/week 
40% One repetition maximum (kg) 
48.6% Muscular endurance (repetitions) 
Kopple 2006 
[111] 
Exercise group  
(n= 10 patients) 
9 weeks Endurance 
exercise training 
 51% skeletal muscle myostatin mRNA 
41% mRNA levels for IGF-IR  
Manfredini 
2009 [63] 
Exercise group  
(n=14 HD patients) 
Control group  
(n=8 HD patients) 
6 months Aerobic Walking 1.5km/h and 0.1 km/h 
every 10 m,  
2 daily indoor/outdoor walking 
sessions for 10 min each 
12.6% 6MWT (m) 
37.8% e-CFUs (colonies/ml) 
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Kumar 2010 
[68] 
Exercise group (n=23) 1 month Isometric Squeezing a tennis ball 30 
min/day 
Handgrip strength (kg) 
Systolic blood pressure (mmHg) 
Vessel diameters 
Arterial blood velocity 
Takashi 
Aoike 2012 
[59] 
Exercise group 
 (n=10 CKD patients 
stage 2-3) 
3 months Aerobic Treadmill at VT,  
3 times/week 
19.4% VO2peak (ml/kg/min) 
15.1% VE (L/min) 
9.1% 6MWT (m) 
19.7% 2-minutes step test (steps)  
15.8% TUG (s) 
11.1% Sit & reach test (cm) 
20.3% Arm curl test-right arm (repetitions) 
15.7% Arm curl test-left arm (repetitions) 
34.6% STS (repetitions) 
Song 2012 
[66] 
Exercise group  
(= 20 HD patients) 
Control group  
(n=20 HD patients) 
3 months Progressive 
resistance 
training 
20-30 min six routine upper & 
lower body movements,  
3 times/week 
13% Leg muscle strength (kg) 
9.2% Total cholesterol (mg/dl) 
17.6% Triglyceride (mg/dl) 
Howden 2013 
[60] 
Exercise group 
 (n=36, CKD patients 
stage 3-4) 
Control group  
(n=36 CKD patients stage 
3-4) 
12 months Combined 
(aerobic & 
resistance) 
Warm-up, 20-30 min treadmill 
or stationery bike or rowing 
ergometer & whole-body 
resistance training, 2-3 
times/week 
11.6% Vo2peak (ml/kg/min) 
4.3% EA (mmHg/ml) 
 
Molsted 2013 
[112] 
Exercise group  
(n=29 HD patients) 
4 months Resistance 5 min warm-up, five sets of 
legs presses, leg extensions, leg 
curls, 30 min, 3 times/week 
46.4% 1 repetition maximum knee extension 
(kg) 
134% 1 repetition maximum leg press (kg) 
Kong 2014 
[69] 
Grip exercise group  
(n=10 HD patients) 
soft ball exercise group 
(n=8 HD patients) 
1 month Strength 10 squeezes in grip strength at 
10 RM for  3 set, 2 
times/weeks, 3 sets of 10 soft 
ball squeezes 2 times in the 
morning & in the afternoon 
33.3%/8.3% Tip pinch (kg) 
26.6%/ Palmar pinch (kg) 
32.2%/13.3% Lateral pinch (kg) 
54.6% Grip strength (kg) 
3.2%/2% Circumference (cm) 
27.2%/32.1% Vessel size (mm) 
92.4%/56.4% Blood flow volume (ml/min) 
Headley 2014 
[36] 
Exercise group  
(n=25 CKD patients) 
control group  
(n=21 CKD patients ) 
4 months Aerobic 15-55 min continuous aerobic 
exercise at 50-60%,   
3 times/week 
8.2% Vo2peak (ml/kg/min) 
18% ET-1 (fmol/ml) 
29.5% NO:ET-1 ratio 
Molsted 2014 
[64] 
Exercise group  
(n=23 HD patients) 
4 months Resistance 5 min warm-up, 5 sets of 
dynamic leg press,  
24% Left leg muscle power (W/kg) 
25.1% Right leg muscle power (W/kg) 
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extension & curl,  
3 times/week 
21.4 % Chair stand test (repetitions) 
Hamada 2015 
[65] 
Exercise group  
(n=47 CKD patients) 
6 month Combined 1,5-2 h/ session, resistance 
training at 3-4METs, 
Walking, 12-14 RPE 
6 times/month 
30% 30 s Chair stand test 
8.3% Sit & reach test (cm) 
29% Single-foot standing test (s) 
5.4% 6 MWT (m) 
VT: ventilatory threshold; LVIDd: left ventricular internal dimension at end-diastole; LVM: left ventricular mass; LVMI: left ventricular mass index; LPO: products of lipid peroxidation; 
GSSG/GSH: glutathione redox ratio in serum; MVC: maximum voluntary contraction; IGF-I: insulin-like growth factor-I; 6MWT: 6 min walk test; e-CFUs: endothelial colony-forming unit; 
EA: arterial elastance; ET-1: endothelin 1; NO: nitric oxide. 
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Table 4. Intradialytic exercise training 
Authors Study groups Exercise intervention Outcomes 
  Duration Modality Prescription  
Macdonald 2004 
[72] 
Exercise group 
(=9) 
3 months Interval training High intensity interval training on 
a cycle ergometer 2 min bouts 
≈90% VO2peak followed by 2 
min recovery bouts ≈40% 
VO2peak, 15 bouts/session,  
3 times/week 
24.4% Knee extensor strength 
 ≈25% 30-s Sit to stand  
Storer 2005 [73] Exercise group  
(n=12) 
 Non-exercising group 
 (n=12)  
Healthy group  
(=12) 
10 weeks Aerobic 20-40 min of cycling at 50% 
VO2peak, 3 times/week 
22% Vo2peak (ml/kg/min) 
144% Endurance time (min) 
197% Constant work rate (kJ) 
16% Maximal voluntary muscle strength  
14.7% Stair-climb time (s) 
21.6% Stair-climb power (w) 
18.6% 10 m walk (cm/s) 
14% Timed up & go (s) 
Parsons 2006 [74] Exercise group (n=13) 5 month Aerobic 2 bout x 30 min on cycle 
ergometer or a mini-stepper, 30 
min recovery,  
3 times/week 
14% 6MWT 
12% spKt/V (Jindal) 
15.4% spKt/V (Daugirdas) 
Cheema 2007 
[83] 
Exercise group  
(n=24)  
Control group  
(n=25) 
4 months Resistance 45 min 2 sets of 8 repetitions of 
10 exercises, RPE 15-17, 
 3 times/week 
15.4% Total strength (kg) 
3.3% 6MWT (m) 
10.2% log CRP  
Sakkas 2008 [75] Exercise group (n=7) 
Control (n= 7) 
4 months Aerobic 45 min continuous cycling 45-50 
rpm, at 65-75% watts, 3 
times/week 
28.9% NRSI walk test (s) 
45.3% Total cycling power (w) 
 
Ouzouni 2009 
[113] 
Exercise group (n=19) 
Control group (n=14) 
10 month Combined 30 min cycling, 30 min strength 
and flexibility exercises at 13-14 
RPE,  
3 times/week 
21.1% Vo2peak (ml/kg/min) 
23.6% Exercise time (min) 
23% METs 
 40.7% VE (L/min) 
De Moura 
Reboredo 2010 
[76] 
Exercise group (n=11) 
Control group (n==11) 
3 months Aerobic 10 min warm-up,  
35 min aerobic exercise,  
3 times 
HRV variability 
Echocardiography 
 
Chen 2010 [84] Exercise group (n=22) 
Control group (n=22) 
48 
sessions 
Strength 5 min warm-up, strength exercise 
for the low body using ankle 
weights 0.5-20 lbs, 2 set x 8 
38.5% Knee extensor (kg) 
4.5% Whole-body lean mass by DXA (kg) 
4.3% Leg lean mass by DXA (kg) 
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repetitions, 6-10 RPE,  
2 times/week 
5.4% whole-body fat mass by DXA (%) 
 
Wilund 2010 [77] Exercise group (n=8) 
Control (n=9) 
4 month Aerobic 45 min of cycling at 12-14 RPE  
3 time/week 
17% Shuttle walk test  
38% TBARS (μmol/L) 
27% ALP(U/L) 
11% Epicardial fat thickness (mm) 
de Moura 
Reboredo 2010 
[78] 
Exercise group (n=14) 3 months Aerobic 10 min warm-up  
30 min cycling at 11-13 RPE  
3 times/week 
9% 6MWT (m) 
 5% Systolic blood pressure (mmHg) 
3.3% Diastolic blood pressure (mmHg) 
7.5% Hemoglobin levels (g/dl) 
Singh 2011 [85] Exercise group (n=24) 
Control group (n=25) 
3 months Resistance 45 min  
2 sets x 8 repetitions x 10 
exercises 
 RPE 15-17  
3 times/week 
Interleukin-1β (pg/ml) 
Interleukin-6(pg/ml) 
Interleukin-8(pg/ml) 
Interleukin-10(pg/ml) 
Interleukin-12(pg/ml) 
TNF-α (pg/ml) 
Dobsak 2011 [79] Exercise group (n=) 
Electromyostimulation 
group (n=11) 
Control group (n=10) 
5 months  Aerobic 
 Electromyost
imulation 
Warm-up 5 min, 20 min cycling 
at 60% of Wpeak, after 5 weeks 
2x 20, 3 time/week 
 
14.8% CWT 
16.1% Fmax 
Bullani 2011 [87] Exercise group (n=11) 6 months Resistance 30-40 min exercises with elastic 
resistance, 3 sets x 20 repetition, 
2 times/week 
7.5% Tinetti test (score) 
17.3% TUG (s) 
Golebiowski 2012 
[80] 
Exercise group (n=21) 3 months Aerobic ~50 min cycling, 3 time/week 4% 6MWT velocity 
7% Extension peak torque 
 at angular velocity of 60o/s 
4% Extension peak torque 
 at angular velocity of 300o/s  
13% Flexion peak torque  
at angular velocity of 180o/s  
 
Orcy 2012 [86] Combined exercise group 
(n=12) 
Resistance exercise 
group (n=12) 
10 weeks  Resistance 
 Combined 
20 min cycling at 13-14 RPE & 
10 min of resistance training or 
30 min of resistance training with 
elastic bands, therapeutic balls 
and dumbbells and ankle of 1or 2 
lb, 10-15 repetitions, 3 
times/week 
4.4%/    9% 6MWT (m) 
Ragnarsdottir Exercise group 3 months 3 month Aerobic 12-40 min cycling at 11-13 RPE, 16.3%/22% 6MWT (m) 
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2012 [81] (n=12) 
Exercise group 6 months 
(n=9) 
6 months 3 times/week 16.9%/16.1% TUG 
17.2%/ 23.4% Timed stand test 
Silva 2013 [114] Exercise group (n=56) 16 months Combined 10 min cycling at <60-70% HR, 
strengthening exercises for upper 
& lower limbs, 3 times/week 
9.7% 6MWT (m) 
 
Pellizzaro 2013 
[88] 
Respiratory muscle 
training group (n=11), 
Peripheral muscle 
training group (n=14), 
control group (n=14) 
10 weeks Resistance 3 set x 15 inspirations at 50% of 
PImax or strengthen exercises at 
50% of 1MR, 3 set x 15 
repetitions 
14.2% /   6.8% 6MWT (m) 
21.4%/    25.9%FVC (l) 
Giannaki 2013 
[82] 
Exercise group (n=12) 
Control group (n=12) 
6 months Aerobic 45 min cycling at 60-65% 
VO2peak, 
3 times/week 
10.5% NSRI (s) 
20.5% STS-5 (repetitions) 
22.6% STS-60 (s) 
20% Sleep Diary  
57.8% IRLS (score) 
Moraes 2013 [89] Exercise group (n=26) 
Control group (n=18) 
6 months Resistance Exercises with elastic bands at 
60-70% at 60-70% of 1RM, 3 
times/week 
23% STS-10 (s) 
10.2% STS-60 (repetitions) 
Moraes 2014 [90] Exercise group (n=37) 6 months Resistance Exercises with elastic bands at 
60-70% of 1RM,  
3 times/week 
30.4% CRP (pg/ml) 
18.7% ICAM-I (pg/ml) 
41.7% VCAM-I (pg/ml) 
25.4% FFM/IL-6 (ratio) 
22.5% STS-10 (s) 
11.2% STS- (repetitions) 
spKt/V : a dimensionless value representing fractional urea clearance; Wpeak: peak workload;  MR: maximum repetition; NRSI walk test: North Staffordshire royal infirmary walking test; 
TIIm: time to exercise intolerance; TNF-α: tumor necrosis factor-α; CMT:6-min corridor walking test; Fmax: muscle power; PImax: maximal inspiratory pressure; STS: sit to stand; IRLS: 
restless leg syndrome severity scale;  
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Figure 1. Progress of the literature screening 
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Figure 2. Hemodynamic changes during exercise training in healthy subjects and CKD patients: In healthy subjects during exercise and especially during the first 
minutes, a rapid increase in heart rate, blood pressure and stroke volume occur and accordingly an elevation in cardiac output takes place as an adaptive response to the 
increased muscle metabolic demands for oxygen. In contrast, increased levels of resting heart rate characterize patients with CKD, but during exercise heart rate response is 
decreased and only a small amount of CKD patients can reach the predicted heart rate. Also, they present low levels of blood pressure and higher cardiac output and stroke 
volume. As a consequence of all these and in combination with other abnormalities caused by uremic cardiomyopathy and myopathy oxygen consumption is decreased, 
leading to poor levels of functional capacity and exercise intolerance. 
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Figure 3. Beneficial effects of exercise training in CKD patients: systemic exercise training induces 
beneficial adaptations in the Cardiovascular and Autonomic Nervous systems. 
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